Skip to main content
. Author manuscript; available in PMC: 2015 Apr 14.
Published in final edited form as: Cancer Res. 2014 Jan 2;74(5):1311–1318. doi: 10.1158/0008-5472.CAN-13-1865

Fig. 2.

Fig. 2

Distribution of Fusobacterium in CRC patients (n=149). The cases were ranked according to the amount of pan-fusobacterium (right=high amount, left=low amount). Note that all F. nucleatum high cases (n=8) were included in pan-fusobacterium high cases (n=14) and there is clear separation of FB high group (n=14, 9.4%) and FB low/negative group (n=135, 90.6%). Red, CIMP1, MLH1 methylated, BRAF, KRAS and TP53 mutated; blue, CIMP2; grey CIMP-negative, MLH1 unmethylated, BRAF, KRAS and TP53 wild type; white, not determined;